The Edit vs Taurus Meds
The clearest writing about compounded medication in the category, at $249, against the loudest claims in it, at $129.
The Edit
Editorial
$249/mo
One of the few sellers that calls its product a compounded injectable in the product description itself, and says a prescription is required.
Pick it for: Anyone who weights honesty about regulatory status heavily
Compared against Taurus Meds on price, disclosure and evidence.
Taurus Meds
Editorial
$129/mo
Lists NAD⁺ at $129 against a struck-through $299, on a page whose product copy claims the shot gives near-immortality.
Pick it for: A price-driven buyer who reads past the copy
Compared against The Edit on price, disclosure and evidence.
Our verdict
The Edit prints the sentence nobody else will — that compounded medications are not FDA-approved and the FDA does not verify their safety, effectiveness or quality — and charges $249. Taurus Meds charges $129, says the injection gives near-immortality, and displays an FDA-approved badge beside compounded peptides. Neither product has outcome trials behind it, so you are choosing between paying a premium for candor and paying less to be marketed at.
Scores and verdicts are computed from our published rubric, which does not read commercial status. Where one provider is a paid partner and the other is not, that changes the label on the card and nothing else.
Before you choose either
Ask both for the dose their monthly price buys — most providers in this category do not publish it, and without milligrams the prices are not comparable. Our cost-per-milligram calculator does the arithmetic once you have the numbers. And read what is known about safety — for injectable NAD⁺, less than you would hope.